|
End-of-day quote
Australian S.E.
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Nash
CEO | Chief Executive Officer | - | - |
Andrew Boyd
DFI | Director of Finance/CFO | - | 01/03/2011 |
| Corporate Officer/Principal | - | 01/03/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Nash
BRD | Director/Board Member | - | 01/03/2011 |
Brian McNamee
BRD | Director/Board Member | 70 | - |
Antoni M. Cipa
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.05% | -4.98% | +36.73% | -4.62% | 80.65B | |
| -0.90% | +0.65% | -20.11% | -34.58% | 59.9B | |
| -3.82% | -5.31% | +461.63% | +20.73% | 57B | |
| -6.78% | -5.59% | -5.25% | +27.67% | 53.35B | |
| -2.43% | -2.35% | +8.03% | +163.45% | 49.29B | |
| -2.00% | +0.17% | +63.70% | -18.07% | 32.73B | |
| -2.44% | -2.84% | +48.36% | +91.55% | 25.89B | |
| -0.09% | +6.23% | +18.13% | +218.05% | 23.9B | |
| -0.34% | +1.35% | +60.10% | +122.64% | 17.07B | |
| Average | -2.29% | +1.57% | +74.59% | +65.20% | 44.42B | |
| Weighted average by Cap. | -2.61% | +1.01% | +82.50% | +43.41% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ZTL Stock
Select your edition
All financial news and data tailored to specific country editions
